Discrepancy between magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography imaging in a case of borderline ovarian tumor.
Borderline ovarian tumors have a far more favorable clinical course compared to malignant ovarian tumors. To date, the role of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for the differentiation of an ovarian mass remains controversial. Discrepancy between FDG-PET and magnetic resonance (MR) images is rare but may cause a serious dilemma in decision-making. We report a case of a borderline ovarian tumor showing discrepancy between MR and FDG-PET findings. FDG-PET findings may help with the differentiation of ovarian masses when clinical findings are not coincidental.
Ju
W
W
Department of Obstetrics and Gynecology and Medical Research Institute, College of Medicine, Ewha Womans University, Yangchun-Ku, Seoul, South Korea. goodmorning@ewha.ac.uk
Kim
S C
SC
D000368:Aged; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008279:Magnetic Resonance Imaging; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000473:pathology; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18